We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 184.40 | 182.80 | 184.20 | 63,604 | 10:22:04 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.19 | 400.54M |
From Apr 2019 to Apr 2024
TIDMAMS
RNS Number : 3937E
Advanced Medical Solutions Grp PLC
05 May 2017
Hot Features
Premium
5 May 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that the Trust which manages the Deferred Share Bonus Plan ("Plan") on behalf of the employees of AMS has purchased ordinary shares of 5 pence each ("Ordinary Shares") on 2 May 2017, at a price of 264.07p on behalf of Chris Meredith, Mary Tavener, Simon Coates, Rose Guang, Eddie Johnson, Becky Walmsley and Jeff Willis ("PDMRs") as part of the Deferred Share Bonus Plan and, under the terms of the Plan, these shares will be held in trust on their behalf.
Following these transactions the beneficial ownership of the PDMRs is as follows:
Director/PDMR Date purchased Shares purchased Resultant
holding
================== ================ ================= ==========
Chris Meredith
Chief Executive
Officer 2 May 2017 2,186 1,192,508
================== ================ ================= ==========
Mary Tavener
Chief Financial
Officer 2 May 2017 1,684 1,829,813
================== ================ ================= ==========
Simon Coates
PDMR 2 May 2017 4,382 79,481
================== ================ ================= ==========
Rose Guang
PDMR 2 May 2017 7,224 36,059
================== ================ ================= ==========
Eddie Johnson
PDMR 2 May 2017 7,157 52,195
================== ================ ================= ==========
Becky Walmsley
PDMR 2 May 2017 2,381 3,469
================== ================ ================= ==========
Jeff Willis
PDMR 2 May 2017 5,226 130,085
================== ================ ================= ==========
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Chris Meredith
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 2,186 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Mary Tavener
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 1,684 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Simon Coates
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 4,382 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Rose Guang
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 7,224 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Eddie Johnson
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 7,157 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Becky Walmsley
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 2,381 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Jeff Willis
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 5,226 Ordinary Shares as part of the
Deferred Share Bonus Plan on 2 May 2017
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 02/05/2017
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBRGDUBGGBGRU
(END) Dow Jones Newswires
May 05, 2017 13:03 ET (17:03 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
